Study finds no evidence that prostate cancer drugs interact with anticoagulants to increase bleeding, clotting risks

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
News-Medical.Net on MSN

Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

How one receptor can help—or hurt—your blood vessels

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels—one inflammatory and one protective. This protein, a ...
EurekAlert!

Do prostate cancer drugs interact with certain anticoagulants to increase bleeding and clotting risks?

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants published by Wiley online in CANCER, investigators found ...
Medscape

Androgen Receptor Pathway Inhibitors Show Improved Outcomes in Prostate Cancer

In patients with prostate cancer, androgen receptor pathway inhibitors (ARPIs) extended the median time to no longer clinically benefitting (NLCB) to 11.1 months compared with the 6.9 months seen with ...
Renal & Urology News

Dual Androgen Receptor Ligand Degrader, Antagonist Shows Efficacy in mCRPC

The investigational drug BMS-986365 may help patients with mCRPC previously treated with ARPIs overcome drug resistance, despite their genomic status. The investigational dual androgen receptor ...

Umbrella Labs Tesamorelin Peptide Research Use Only Program Advances High Rigor GHRH Receptor Signaling, GH Axis Modeling, And Endocrine Systems Bench Science

TUCSON, AZ / ACCESS Newswire / February 19, 2026 / Umbrella Labs today announced expanded research procurement availability of tesamorelin in lyophilized vial format to support laboratories building ...